The Dutch hypothesis (chronic non-specific lung disease) revisited

In 1961 the hypothesis (later referred to as the Dutch Hypothesis (DH)) was put forward that asthma, chronic bronchitis and emphysema should be considered as different expressions of one disease entity, in which both endogenous (host) and exogenous (environmental) factors play a role in the pathogenesis. A hereditary predisposition to develop allergy and bronchial hyperreactivity were considered to be important denominators of disease susceptibility. Complications and complicating diseases would also contribute to the ultimate phenotype of the patient. In the present paper we discuss the relevance of this hypothesis in 1990. Until now it has not been refuted; circumstantial evidence in its favour has accumulated, but formal proof is still lacking. Further research should pay more attention to the genetic aspects of the disease. Arguments are presented against the use of the terms asthma, chronic bronchitis, and emphysema as indicators of disease entities, and in favour of the use of an umbrella-term, e.g. chronic non-specific lung disease (CNSLD), provided that, in addition, every patient is characterized using so-called defining criteria.

This article has been cited by other articles:

				J-Q. He, K. Shumansky, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD Eur. Respir. J., July 1, 2008; 32(1): 25 - 34. [Abstract] [Full Text] [PDF]

				V. Bellia, C. Pedone, F. Catalano, A. Zito, E. Davi, S. Palange, F. Forastiere, and R. A. Incalzi Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality Chest, October 1, 2007; 132(4): 1175 - 1182. [Abstract] [Full Text] [PDF]

				J. A. Elias, M. J. Kang, K. Crouthers, R. Homer, and C. G. Lee State of the Art. Mechanistic Heterogeneity in Chronic Obstructive Pulmonary Disease: Insights from Transgenic Mice Proceedings of the ATS, August 1, 2006; 3(6): 494 - 498. [Abstract] [Full Text] [PDF]

				D. S. Postma, D. A. Meyers, H. Jongepier, T. D. Howard, G. H. Koppelman, and E. R. Bleecker Genomewide Screen for Pulmonary Function in 200 Families Ascertained for Asthma Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 446 - 452. [Abstract] [Full Text] [PDF]

				D. S. Postma and H. M. Boezen Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S. [Abstract] [Full Text] [PDF]

				J. Elias The Relationship Between Asthma and COPD: Lessons From Transgenic Mice Chest, August 1, 2004; 126(2_suppl_1): 111S - 116S. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]

				J.-Q. He, J. E. Connett, N. R. Anthonisen, and A. J. Sandford Polymorphisms in the IL13, IL13RA1, and IL4RA Genes and Rate of Decline in Lung Function in Smokers Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 379 - 385. [Abstract] [Full Text] [PDF]

				F. Rasmussen, D. R. Taylor, E. M. Flannery, J. O. Cowan, J. M. Greene, G. P. Herbison, and M. R. Sears Risk Factors for Airway Remodeling in Asthma Manifested by a Low Postbronchodilator FEV1/Vital Capacity Ratio: A Longitudinal Population Study from Childhood to Adulthood Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1480 - 1488. [Abstract] [Full Text] [PDF]

				S. Baldacci, E. Omenaas, and M.P. Oryszczyn Allergy markers in respiratory epidemiology Eur. Respir. J., April 1, 2001; 17(4): 773 - 790. [Abstract] [Full Text] [PDF]

				F. Rasmussen, H. C. Siersted, J. Lambrechtsen, H. S. Hansen, and N.-C. G. Hansen Impact of Airway Lability, Atopy, and Tobacco Smoking on the Development of Asthma-Like Symptoms in Asymptomatic Teenagers Chest, May 1, 2000; 117(5): 1330 - 1335. [Abstract] [Full Text] [PDF]

				M. R Becklake and F. Kauffmann Gender differences in airway behaviour over the human life span Thorax, December 1, 1999; 54(12): 1119 - 1138. [Full Text]

				H. A. Boushey Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 1999; 340(25): 1990 - 1991. [Full Text]

				P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen A 15-Year Follow-Up Study of Ventilatory Function in Adults with Asthma N. Engl. J. Med., October 22, 1998; 339(17): 1194 - 1200. [Abstract] [Full Text] [PDF]

				C. I. M. PANHUYSEN, E. R. BLEECKER, G. H. KOETER, D. A. MEYERS, and D. S. POSTMA Characterization of Obstructive Airway Disease in Family Members of Probands with Asthma . An Algorithm for the Diagnosis of Asthma Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1734 - 1742. [Abstract] [Full Text] [PDF]

				R. M. SENIOR and N. R. ANTHONISEN Chronic Obstructive Pulmonary Disease (COPD) Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S139 - S147. [Full Text] [PDF]

				N. M. CLARK, W. C. BAILEY, and C. RAND Advances in Prevention and Education in Lung Disease Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S155 - S167. [Full Text] [PDF]

				C. H. BODNER, S. ROSS, J. LITTLE, J. GRAHAM DOUGLAS, J. S. LEGGE, J. A. R. FRIEND, and D. J. GODDEN Risk Factors for Adult Onset Wheeze . A Case Control Study Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 35 - 42. [Abstract] [Full Text]

				D. S. Postma and M. D. Lebowitz Persistence and New Onset of Asthma and Chronic Bronchitis Evaluated Longitudinally in a Community Population Sample of Adults Arch Intern Med, July 10, 1995; 155(13): 1393 - 1399. [Abstract] [PDF]

				N. R. Anthonisen, J. E. Connett, J. P. Kiley, M. D. Altose, W. C. Bailey, A. S. Buist, W. A. Conway Jr, P. L. Enright, R. E. Kanner, P. O'Hara, et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study JAMA, November 16, 1994; 272(19): 1497 - 1505. [Abstract] [PDF]